Shortage reports
Actual shortage:
257 (7%)
Anticipated shortage:
3 (0%)
Avoided shortage:
11 (0%)
Resolved:
3300 (92%)
3571
Discontinuation Reports
To be discontinued:
24 (7%)
Discontinued:
342 (93%)
Reversed:
0 (0%)
366
143 (4%)
32 (11%)
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-QUINAPRIL/HCTZ | 12.5MG 10MG | TABLET | Resolved | 2022-03-25 | 2025-07-11 | 157326 |
| APO-QUINAPRIL/HCTZ | 25MG 20MG | TABLET | Resolved | 2021-11-05 | 2025-07-11 | 148876 |
| APO-QUINAPRIL/HCTZ | 20MG 12.5MG | TABLET | Resolved | 2020-06-04 | 2020-09-14 | 116564 |
| APO-QUINAPRIL/HCTZ | 20MG 12.5MG | TABLET | Resolved | 2020-10-21 | 2020-11-23 | 126774 |
| APO-QUINAPRIL/HCTZ | 25MG 20MG | TABLET | Resolved | 2019-07-12 | 2019-11-25 | 89167 |
| APO-QUINAPRIL/HCTZ | 12.5MG 10MG | TABLET | Resolved | 2017-11-28 | 2018-04-18 | 31022 |
| APO-QUINAPRIL/HCTZ | 25MG 20MG | TABLET | Resolved | 2018-11-30 | 2019-03-16 | 68245 |
| APO-QUINAPRIL/HCTZ | 12.5MG 10MG | TABLET | Resolved | 2019-08-07 | 2019-09-23 | 91103 |
| APO-QUINAPRIL/HCTZ | 20MG 25MG | TABLET | Resolved | 2020-04-13 | 2020-09-01 | 111954 |
| APO-QUINAPRIL/HCTZ | 10MG 12.5MG | TABLET | Resolved | 2021-02-12 | 2021-05-10 | 133994 |
| APO-QUINAPRIL/HCTZ | 12.5MG 20MG | TABLET | Resolved | 2022-03-04 | 2025-07-11 | 156039 |
| APO-QUINAPRIL/HCTZ | 12.5MG 20MG | TABLET | Resolved | 2019-01-03 | 2019-03-15 | 71145 |
| APO-QUINAPRIL/HCTZ | 25MG 20MG | TABLET | Resolved | 2017-11-28 | 2018-11-02 | 31025 |
| APO-QUINAPRIL/HCTZ | 12.5MG 20MG | TABLET | Resolved | 2017-09-27 | 2018-03-29 | 23638 |
| APO-QUININE CAPSULES | 200MG | CAPSULE | Resolved | 2017-12-14 | 2018-04-17 | 32809 |
| APO-QUININE CAPSULES | 300MG | CAPSULE | Resolved | 2017-09-04 | 2018-04-17 | 20894 |
| APO-RABEPRAZOLE | 20MG | TABLET (ENTERIC-COATED) | Resolved | 2018-07-04 | 2018-07-17 | 54309 |
| APO-RABEPRAZOLE | 10MG | TABLET (ENTERIC-COATED) | Resolved | 2017-04-11 | 2017-05-25 | 6516 |
| APO-RABEPRAZOLE | 20MG | TABLET (ENTERIC-COATED) | Resolved | 2017-07-11 | 2017-07-27 | 15375 |
| APO-RABEPRAZOLE | 20MG | TABLET (ENTERIC-COATED) | Resolved | 2017-03-11 | 2017-05-23 | 466 |
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| MELPHALAN FOR INJECTION | 10ML 50MG | POWDER FOR SOLUTION KIT SOLUTION | Discontinued | 2022-03-23 | 2022-03-23 | 157136 |
| NAPROXEN SODIUM TABLETS | 220MG | TABLET | Discontinued | 2019-01-04 | 2019-01-04 | 71228 |
| PENTOXIFYLLINE SR | 400MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2018-10-23 | 2022-01-27 | 65438 |
| TEMAZEPAM | 15MG | CAPSULE | Discontinued | 2018-10-23 | 2019-01-14 | 65477 |
| TEMAZEPAM | 30MG | CAPSULE | Discontinued | 2018-10-23 | 2019-01-07 | 65482 |
| TIGECYCLINE | 50MG | POWDER FOR SOLUTION | To be discontinued | 2019-06-21 | 2019-06-21 | 87218 |